Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antioxidants for Unexplained Oligohydramnios
NCT01990690Phase 4Completed
- Sponsor
- Woman's Health University Hospital
- Start
- Jan 2015
- Primary completion
- Jul 2015
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of omega-3 fatty acid, vitamin e in Oligohydramnios (Oligo), sponsored by Woman's Health University Hospital. Started Jan 2015; status: completed.
02
Drugs
omega-3 fatty acidvitamin e
03
Conditions
Oligohydramnios (Oligo)
Beyond the preview
Go deeper on NCT01990690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01990690.